AVP and congestive heart failure: High copeptin levels after AMI are linked to prognostically worse outcomes, such as larger infarct sizes, post-infarction left-ventricular dysfunction and cardiac remodeling [67,68], indicating that they can serve as a predictor for major cardiac adverse events [69,70] as well as a predictor for mortality and morbidity in patients with CHF after AMI [71].